Safety and Varicella Outcomes in In Utero–Exposed Newborns and Preterm Infants Treated With Varicella Zoster Immune Globulin (VARIZIG): A Subgroup Analysis of an Expanded-Access Program

BACKGROUND: Infants exposed to varicella zoster virus (VZV) in utero ≤5 days before or ≤48 hours after delivery and preterm infants are at high risk for varicella complications. An expanded-access program assessed varicella outcomes after administration of varicella zoster immune globulin (human) (V...

Descripción completa

Detalles Bibliográficos
Autores principales: Duchon, Jennifer M, Levin, Myron J, Gershon, Anne A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495903/
https://www.ncbi.nlm.nih.gov/pubmed/31774916
http://dx.doi.org/10.1093/jpids/piz070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495903/
https://www.ncbi.nlm.nih.gov/pubmed/31774916
http://dx.doi.org/10.1093/jpids/piz070

Ejemplares similares